HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

mouse Chrna7 protein

RefSeq NM_007390

Also Known As:

Chrna7 protein, mouse; alpha7-nAChR protein, mouse; cholinergic receptor, nicotinic, alpha 7; cholinergic receptor, nicotinic, alpha polypeptide 7, mouse

Networked: 4 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Carrier Proteins: 12999
    - Membrane Transport Proteins: 589
      - Ion Channels: 6731
        Ligand-Gated Ion Channels: 221
        Cysteine Loop Ligand-Gated Ion Channel Receptors: 14
        Nicotinic Receptors: 3452
        alpha7 Nicotinic Acetylcholine Receptor: 167
        mouse Chrna7 protein: 4
  - Membrane Proteins: 10078

Experts

1.	Geyik, Sırma: 1 article (09/2021)
2.	Yılmaz, Şenay Görücü: 1 article (09/2021)
3.	Özaltun, Mehmet Fatih: 1 article (09/2021)
4.	Chen, Yuping: 1 article (01/2021)
5.	Du, Liang: 1 article (01/2021)
6.	Gao, Shegan: 1 article (01/2021)
7.	Geary, Kyla: 1 article (01/2021)
8.	Guo, Yi: 1 article (01/2021)
9.	Lin, Yusheng: 1 article (01/2021)
10.	Pan, Yunlong: 1 article (01/2021)

Related Diseases

1.	Migraine Disorders (Migraine) 09/07/2021 - "We investigated the effects of the CNV and gene expression at the location 15q13.3 in the Cholinergic Receptor Nicotinic Alpha 7 Subunit (CHRNA7) gene, which we believe to be effective in the migraine clinic. " 01/01/2023 - "CNVs, the Cholinergic Receptor Nicotinic Alpha 7 Subunit (CHRNA7) gene, and expression of gene-targeting miRNAs (hsa-miR-548e-5p and hsa-miR-3158-5p) in migraineurs (n = 102; with aura, n = 43; without aura, n = 59) and non-migraines (n = 120) aged 15-60 years, comparative, case-control study was conducted. "
2.	Cognitive Dysfunction 06/01/2016 - "The Single Nucleotide Polymorphisms in the Cholinergic Receptor, Nicotinic, Alpha 7 gene (CHRNA7), Glutamate (NMDA) Receptor, Metabotropic 1 (GRM1) gene, Dystrobrevin Binding Protein 1 (DTNBP1) and kynurenine 3-monooxygenase (KMO) gene may predict treatment response to galantamine and memantine combination for cognitive impairments in schizophrenia in the kynurenine pathway."
3.	Schizophrenia (Dementia Praecox) 06/01/2016 - "The Single Nucleotide Polymorphisms in the Cholinergic Receptor, Nicotinic, Alpha 7 gene (CHRNA7), Glutamate (NMDA) Receptor, Metabotropic 1 (GRM1) gene, Dystrobrevin Binding Protein 1 (DTNBP1) and kynurenine 3-monooxygenase (KMO) gene may predict treatment response to galantamine and memantine combination for cognitive impairments in schizophrenia in the kynurenine pathway."
4.	Neoplasms (Cancer) 01/01/2021 - "Here we report that nicotine enhances ESCC cancer malignancy and tumor-initiating capacity by interacting with cholinergic receptor nicotinic alpha 7 subunit (CHRNA7) and subsequently activating the JAK2/STAT3 signaling pathway. "
5.	Epilepsy (Aura) 01/01/2023 - "CNVs, the Cholinergic Receptor Nicotinic Alpha 7 Subunit (CHRNA7) gene, and expression of gene-targeting miRNAs (hsa-miR-548e-5p and hsa-miR-3158-5p) in migraineurs (n = 102; with aura, n = 43; without aura, n = 59) and non-migraines (n = 120) aged 15-60 years, comparative, case-control study was conducted. "

Related Drugs and Biologics

1.	Kynurenine 3-Monooxygenase (Kynurenine 3 Monooxygenase)
2.	MicroRNAs (MicroRNA)
3.	Glutamic Acid (Glutamate)
4.	N-Methyl-D-Aspartate Receptors (NMDA Receptors)
5.	Nicotine
6.	Memantine (Namenda)
7.	Kynurenine
8.	Galantamine (Galanthamine)
9.	Dysbindin